NCT07592624

Brief Summary

The goal of this RCT is to evaluate the effect of the instructional video on improving patient compliance and reducing medication errors. The study will include adult kidney transplant recipients (18 years or older) at Erasmus MC who have undergone a kidney transplantation starting January 2026. The main questions it aims to answer: The primary aim of this study is to assess whether our developed video instruction, compared with the traditional verbal instruction, both of which are given shortly before training during admission, reduces the number of medication errors in kidney transplant patients. The study will also examine the correlation between patient characteristics (such as age, comorbidities, and language proficiency) and medication errors. Additionally, patient-reported medication errors will be measured through a questionnaire completed during follow-up visits at the outpatient clinic, which is part of standard care. The instructional video will be evaluated by a short questionnaire.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
308

participants targeted

Target at P75+ for not_applicable

Timeline
18mo left

Started Jul 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 18, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2026

Expected
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2027

7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

May 18, 2026

Status Verified

May 1, 2026

Enrollment Period

11 months

First QC Date

March 12, 2026

Last Update Submit

May 11, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence and type of medication errors during admission

    The primary outcome of this study will be the incidence (number of medication errors) and type of medication errors ( 1)Medication preparation omitted, 2) Incorrect dosage, 3) Incorrect administration at the scheduled time, 4), Medication discontinued inappropriately, 5)Error not documented by the nurse) during admission, evaluated through direct observation by healthcare providers. These errors will be documented and reported via patient portals by nurses.

    During admission

Secondary Outcomes (3)

  • Patient characteristics

    During admission

  • Evaluation of the instructional video

    At the end of admission

  • BAASIS

    During the first year follow up at the out patient clinic after kidney transplantation in the Erasmus MC

Study Arms (2)

Verbal instruction

NO INTERVENTION

Patients receive the verbal instruction about medication training from the nurses.

Video instruction

EXPERIMENTAL

Patients receive the instruction video about medication training from the nurses.

Other: Instructional video about medication administration

Interventions

Self developed instructional video for a Dutch university hospital, for Dutch kidney transplant patients. Instructional video is about medication administration during admission.

Video instruction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient is able to take the medication independently or with the help of someone else (professionals not included).
  • After admission, the patient is discharged to their own home or home of friend/relative.
  • The patient had a follow up at the outpatient clinic in the Erasmus Medical Center for at least one year after transplantation.
  • The patient is able to read the medication list or an illiteracy-friendly medication list.

You may not qualify if:

  • Patients under 18 years of age
  • Patients who got discharged with a medication dispenser
  • Refusal to participate in the study.
  • Cognitive impairments that hinder participation.
  • Patients and/or family who can not understand (language barrier) the instructional video.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasmus Medical Center

Rotterdam, 3015GD, Netherlands

Location

MeSH Terms

Conditions

Medication Adherence

Condition Hierarchy (Ancestors)

Patient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Jacqueline van de Wetering, MD, Dr.

    Erasmus Medical Center

    STUDY CHAIR

Central Study Contacts

Myrthe van der Zanden, MSc, Drs

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 12, 2026

First Posted

May 18, 2026

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

May 18, 2026

Record last verified: 2026-05

Locations